Cargando…

Foam Sclerotherapy for Conjunctival Inclusion Cyst Post Evisceration

Orbital conjunctival epithelial cysts have traditionally been excised, with the risk of leaving behind remnants that may result in recurrences. We present an 18-year-old male who complained of a poorly retained prosthesis three years after a primary evisceration and polymethylmethacrylate (PMMA) bal...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Rwituja, Grover, Ashok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406155/
https://www.ncbi.nlm.nih.gov/pubmed/37554591
http://dx.doi.org/10.7759/cureus.41570
_version_ 1785085690146455552
author Thomas, Rwituja
Grover, Ashok
author_facet Thomas, Rwituja
Grover, Ashok
author_sort Thomas, Rwituja
collection PubMed
description Orbital conjunctival epithelial cysts have traditionally been excised, with the risk of leaving behind remnants that may result in recurrences. We present an 18-year-old male who complained of a poorly retained prosthesis three years after a primary evisceration and polymethylmethacrylate (PMMA) ball implant. We performed cyst aspiration and injection foam sclerotherapy for the cyst, which resolved completely in six weeks, allowing the prosthesis to be retained comfortably. Aspiration and injection of sclerosing agents may result in the collapse of the cyst along with fibrosis of their walls with obliteration of the lumen, resulting in complete resolution.
format Online
Article
Text
id pubmed-10406155
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104061552023-08-08 Foam Sclerotherapy for Conjunctival Inclusion Cyst Post Evisceration Thomas, Rwituja Grover, Ashok Cureus Ophthalmology Orbital conjunctival epithelial cysts have traditionally been excised, with the risk of leaving behind remnants that may result in recurrences. We present an 18-year-old male who complained of a poorly retained prosthesis three years after a primary evisceration and polymethylmethacrylate (PMMA) ball implant. We performed cyst aspiration and injection foam sclerotherapy for the cyst, which resolved completely in six weeks, allowing the prosthesis to be retained comfortably. Aspiration and injection of sclerosing agents may result in the collapse of the cyst along with fibrosis of their walls with obliteration of the lumen, resulting in complete resolution. Cureus 2023-07-08 /pmc/articles/PMC10406155/ /pubmed/37554591 http://dx.doi.org/10.7759/cureus.41570 Text en Copyright © 2023, Thomas et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Ophthalmology
Thomas, Rwituja
Grover, Ashok
Foam Sclerotherapy for Conjunctival Inclusion Cyst Post Evisceration
title Foam Sclerotherapy for Conjunctival Inclusion Cyst Post Evisceration
title_full Foam Sclerotherapy for Conjunctival Inclusion Cyst Post Evisceration
title_fullStr Foam Sclerotherapy for Conjunctival Inclusion Cyst Post Evisceration
title_full_unstemmed Foam Sclerotherapy for Conjunctival Inclusion Cyst Post Evisceration
title_short Foam Sclerotherapy for Conjunctival Inclusion Cyst Post Evisceration
title_sort foam sclerotherapy for conjunctival inclusion cyst post evisceration
topic Ophthalmology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406155/
https://www.ncbi.nlm.nih.gov/pubmed/37554591
http://dx.doi.org/10.7759/cureus.41570
work_keys_str_mv AT thomasrwituja foamsclerotherapyforconjunctivalinclusioncystpostevisceration
AT groverashok foamsclerotherapyforconjunctivalinclusioncystpostevisceration